ArticlePharmaceuticals (Basel, Switzerland)2022
Analysis of Adverse Events in the Treatment of Patients with Non-Valvular Atrial Fibrillation with Oral Anticoagulants: Data from the "ANTEY" Observational Study.
Sergey Yu Martsevich et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.